Ratings by Citizens (Jonathan Wolleben)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | Sionna Therapeutics | SION | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/17/2026 | Opus Genetics | IRD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/16/2026 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/16/2026 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/15/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/15/2026 | Opus Genetics | IRD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/11/2026 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/3/2026 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/2/2026 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/1/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/1/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/27/2026 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/26/2026 | Sionna Therapeutics | SION | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/19/2026 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/15/2026 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/14/2026 | Nexxen | NEXN | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/14/2026 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/14/2026 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/13/2026 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/13/2026 | Kalaris | KLRS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/13/2026 | Opus Genetics | IRD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/12/2026 | MBX Biosciences Inc | MBX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/8/2026 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/7/2026 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/6/2026 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/5/2026 | Opus Genetics | IRD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/5/2026 | Biomea Fusion Inc. | BMEA | New Coverage | Market Outperform (N/A) |
1.37 (1.27) |
-7.3% | Details | |
| 5/4/2026 | Opus Genetics | IRD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/1/2026 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/29/2026 | Kalvista Pharmaceuticals Inc | KALV | Downgrade | Market Perform (Market Outperform) |
19.24 (27.00) |
40.33% | Details | |
| 4/28/2026 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/28/2026 | Opus Genetics | IRD | New Coverage | Market Outperform (N/A) |
5.23 (4.04) |
-22.75% | Details | |
| 4/16/2026 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/31/2026 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/27/2026 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/26/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/26/2026 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/25/2026 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/24/2026 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/23/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/18/2026 | Kalaris | KLRS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/17/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/17/2026 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/17/2026 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/13/2026 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/13/2026 | MBX Biosciences Inc | MBX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/12/2026 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/11/2026 | Skye Bioscience | SKYE | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/2/2026 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/2/2026 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/27/2026 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/27/2026 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/26/2026 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/26/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/24/2026 | Sionna Therapeutics | SION | New Coverage | Market Outperform (N/A) |
35.49 (39.18) |
10.4% | Details | |
| 2/23/2026 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2026 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/30/2026 | Quince Therapeutics Inc. | QNCX | Downgrade | Market Perform (Market Outperform) |
3.18 (0.98) |
-69.18% | Details | |
| 1/22/2026 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/20/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/15/2026 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/13/2026 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/9/2026 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/9/2026 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/8/2026 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/6/2026 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/5/2026 | Skye Bioscience | SKYE | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/19/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/18/2025 | Kalaris | KLRS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/17/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/16/2025 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/15/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/12/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/12/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/12/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/11/2025 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/8/2025 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/25/2025 | Kalaris | KLRS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/24/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/19/2025 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/19/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/14/2025 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/13/2025 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/13/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/13/2025 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/12/2025 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/11/2025 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/11/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/7/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/7/2025 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/5/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 11/5/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/3/2025 | Kalaris | KLRS | New Coverage | Market Outperform (N/A) |
4.74 (4.49) |
-5.27% | Details | |
| 10/28/2025 | Spruce Biosciences, Inc. | SPRB | Upgrade | Market Outperform (Market Perform) |
133.24 (52.49) |
-60.6% | Details | |
| 10/24/2025 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/23/2025 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/16/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/15/2025 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/15/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/15/2025 | Astria Therapeutics | ATXS | Downgrade | Market Perform (Market Outperform) |
8.47 (12.58) |
48.52% | Details | |
| 10/15/2025 | Astria Therapeutics | ATXS | Downgrade | Market Perform (Market Outperform) |
8.47 (8.47) |
0% | Details | |
| 10/7/2025 | MBX Biosciences Inc | MBX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/6/2025 | Skye Bioscience | SKYE | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/6/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/3/2025 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/3/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 10/1/2025 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/30/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/26/2025 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/26/2025 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/25/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/17/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/17/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/16/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/12/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 9/10/2025 | Skye Bioscience | SKYE | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/21/2025 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/21/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/20/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/19/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/15/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/13/2025 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/13/2025 | Astria Therapeutics | ATXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/12/2025 | Quince Therapeutics Inc. | QNCX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/11/2025 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/7/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/7/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/7/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/6/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 8/5/2025 | Quince Therapeutics Inc. | QNCX | New Coverage | Market Outperform (N/A) |
1.68 (3.18) |
89.29% | Details | |
| 7/22/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/17/2025 | Clearside Biomedical | CLSD | Downgrade | Market Perform (Market Outperform) |
0.84 (0.41) |
-51.19% | Details | |
| 7/17/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/16/2025 | MBX Biosciences Inc | MBX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/16/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/15/2025 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/14/2025 | Rhythm Pharmaceuticals | RYTM | Upgrade | Market Outperform (Market Outperform) |
86.70 (108.88) |
25.58% | Details | |
| 7/10/2025 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/8/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/2/2025 | MBX Biosciences Inc | MBX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/2/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/2/2025 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 7/2/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/27/2025 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/26/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/26/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/24/2025 | Skye Bioscience | SKYE | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/23/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/17/2025 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/16/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/5/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/5/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/5/2025 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 6/5/2025 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/29/2025 | Astria Therapeutics | ATXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/27/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/23/2025 | Aura Biosciences | AURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/19/2025 | Aura Biosciences | AURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/16/2025 | Clearside Biomedical | CLSD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/14/2025 | Astria Therapeutics | ATXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/9/2025 | Mirum Pharmaceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/24/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 4/23/2025 | Skye Bioscience | SKYE | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Rallybio Corp. | RLYB | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 4/23/2025 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | MBX Biosciences Inc | MBX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Clearside Biomedical | CLSD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Aura Biosciences | AURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Astria Therapeutics | ATXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/23/2025 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/15/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/10/2025 | MBX Biosciences Inc | MBX | New Coverage | Market Outperform (N/A) |
5.79 (46.41) |
701.55% | Details | |
| 4/8/2025 | Rallybio Corp. | RLYB | Downgrade | Market Perform (Market Outperform) |
0.42 (15.85) |
3673.81% | Details | |
| 4/2/2025 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/28/2025 | Clearside Biomedical | CLSD | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/27/2025 | Savara | SVRA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/27/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/26/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/26/2025 | Aura Biosciences | AURA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/21/2025 | Skye Bioscience | SKYE | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/14/2025 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/10/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/6/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/4/2025 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/4/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/3/2025 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2025 | Astria Therapeutics | ATXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/28/2025 | Structure Therapeutics | GPCR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/28/2025 | Crinetics | CRNX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/27/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/27/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/25/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/24/2025 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/19/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2025 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2025 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/18/2025 | Astria Therapeutics | ATXS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/7/2025 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/4/2025 | Rhythm Pharmaceuticals | RYTM | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/31/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/31/2025 | BioCryst Pharma | BCRX | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/31/2025 | Astria Therapeutics | ATXS | Upgrade | Market Outperform (Market Outperform) |
7.46 (12.58) |
68.63% | Details | |
| 1/31/2025 | Pharvaris B.V. | PHVS | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/31/2025 | Astria Therapeutics | ATXS | New Coverage | Market Outperform (N/A) |
7.46 (8.47) |
13.54% | Details | |
| 1/31/2025 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Market Outperform (N/A) |
8.77 (19.24) |
119.38% | Details | |
| 1/27/2025 | Allakos Inc. | ALLK | Downgrade | Market Perform (Market Outperform) |
1.21 (0.33) |
-72.73% | Details | |
| 1/24/2025 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 12/11/2024 | Spruce Biosciences, Inc. | SPRB | Downgrade | Market Perform (Market Outperform) |
0.54 (133.24) |
24574.07% | Details | |
| 9/17/2024 | Rhythm Pharmaceuticals | RYTM | New Coverage | Market Outperform (N/A) |
49.62 (86.70) |
74.73% | Details | |
| 9/13/2024 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/10/2024 | Skye Bioscience | SKYE | New Coverage | Market Outperform (N/A) |
5.84 (0.71) |
-87.84% | Details | |
| 8/15/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/13/2024 | Savara | SVRA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Structure Therapeutics | GPCR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/7/2024 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/5/2024 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/31/2024 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/16/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/9/2024 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/27/2024 | Savara | SVRA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/18/2024 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/14/2024 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/9/2024 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/8/2024 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/8/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/8/2024 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/7/2024 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/11/2024 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/20/2024 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/14/2024 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/14/2024 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/12/2024 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/29/2024 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/15/2024 | Savara | SVRA | New Coverage | Market Outperform (N/A) |
4.78 (5.86) |
22.59% | Details | |
| 2/13/2024 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/9/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/7/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/7/2024 | Rallybio Corp. | RLYB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/23/2024 | Sagimet Biosciences Inc | SGMT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/23/2024 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/17/2024 | Allakos Inc. | ALLK | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/8/2024 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/19/2023 | Mirum Pharamceuticals | MIRM | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/1/2023 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/15/2023 | Structure Therapeutics | GPCR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/14/2023 | Allakos Inc. | ALLK | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/10/2023 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/7/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/19/2023 | Structure Therapeutics | GPCR | New Coverage | Market Outperform (N/A) |
64.98 (45.99) |
-29.22% | Details | |
| 10/10/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/27/2023 | Allakos Inc. | ALLK | New Coverage | Market Outperform (N/A) |
2.14 (0.33) |
-84.58% | Details | |
| 9/20/2023 | Mirum Pharamceuticals | MIRM | New Coverage | Market Outperform (N/A) |
32.11 (112.47) |
250.26% | Details | |
| 9/11/2023 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/16/2023 | Spruce Biosciences, Inc. | SPRB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/8/2023 | Sagimet Biosciences Inc | SGMT | New Coverage | Market Outperform (N/A) |
16.09 (7.15) |
-55.56% | Details | |
| 7/6/2023 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/26/2023 | Rallybio Corp. | RLYB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/12/2023 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/9/2023 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 4/6/2023 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/30/2023 | ProQR Therapeutics N.V. | PRQR | Upgrade | Market Outperform (Market Perform) |
3.58 (1.92) |
-46.37% | Details | |
| 3/16/2023 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/16/2023 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/10/2023 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/8/2023 | Protagonist Therapeutics | PTGX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/7/2023 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/11/2023 | Pharvaris B.V. | PHVS | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/9/2023 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/5/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/19/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/16/2022 | Spruce Biosciences, Inc. | SPRB | New Coverage | Market Outperform (N/A) |
1.05 (0.54) |
-48.57% | Details | |
| 11/11/2022 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/11/2022 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/19/2022 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/13/2022 | Pharvaris B.V. | PHVS | New Coverage | Market Outperform (N/A) |
9.32 (33.17) |
255.9% | Details | |
| 9/2/2022 | Rallybio Corp. | RLYB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/2/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/2/2022 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/2/2022 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/2/2022 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/2/2022 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/2/2022 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/25/2022 | Protagonist Therapeutics | PTGX | New Coverage | Market Outperform (N/A) |
9.41 (119.74) |
1172.48% | Details | |
| 8/12/2022 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/11/2022 | ProQR Therapeutics N.V. | PRQR | Downgrade | Market Perform (Market Outperform) |
0.84 (1.92) |
128.57% | Details | |
| 8/10/2022 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/9/2022 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Rallybio Corp. | RLYB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/5/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/19/2022 | Aura Biosciences | AURA | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/25/2022 | Pharvaris B.V. | PHVS | New Coverage | Market Outperform (N/A) |
17.00 (33.17) |
95.12% | Details | |
| 5/10/2022 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/10/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/14/2022 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/31/2022 | Crinetics | CRNX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/16/2022 | Rallybio Corp. | RLYB | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/11/2022 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/1/2022 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/22/2022 | Rallybio Corp. | RLYB | New Coverage | Market Outperform (N/A) |
12.91 (0.42) |
-96.75% | Details | |
| 2/15/2022 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/14/2022 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 1/11/2022 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/21/2021 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/30/2021 | Crinetics | CRNX | New Coverage | Market Outperform (N/A) |
24.40 (37.29) |
52.83% | Details | |
| 11/9/2021 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 11/3/2021 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/27/2021 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/25/2021 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/22/2021 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 10/11/2021 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/9/2021 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/11/2021 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/6/2021 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/30/2021 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/16/2021 | Altimmune | ALT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/15/2021 | Clearside Biomedical | CLSD | Maintain | Market Outperform (N/A) |
|
Details | ||
| 6/8/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/26/2021 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 5/11/2021 | Larimar Therapeutics | LRMR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 5/7/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 4/30/2021 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 3/24/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (N/A) |
|
Details | ||
| 2/26/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/26/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/26/2021 | Altimmune | ALT | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/10/2021 | Larimar Therapeutics | LRMR | New Coverage | Market Outperform (N/A) |
18.87 (3.71) |
-80.34% | Details | |
| 1/15/2021 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/29/2020 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 12/4/2020 | BioCryst Pharma | BCRX | Maintain | Market Outperform (N/A) |
|
Details | ||
| 9/29/2020 | Ocular Therapeutix | OCUL | Maintain | Market Outperform (N/A) |
|
Details | ||
| 8/5/2020 | DBV Technologies S.A | DBVT | Maintain | Market Outperform (N/A) |
|
Details | ||
| 7/28/2020 | Altimmune | ALT | New Coverage | Market Outperform (N/A) |
25.63 (2.97) |
-88.41% | Details | |
| 7/21/2020 | Madrigal Pharmaceuticals | MDGL | New Coverage | Market Outperform (N/A) |
107.10 (523.00) |
388.33% | Details | |
| 7/21/2020 | Intercept Pharmaceuticals | ICPT | New Coverage | Market Perform (N/A) |
48.82 (19.00) |
-61.08% | Details | |
| 7/2/2020 | DBV Technologies S.A | DBVT | New Coverage | Market Outperform (N/A) |
4.39 (15.99) |
264.24% | Details | |
| 6/26/2020 | BioCryst Pharma | BCRX | New Coverage | Market Outperform (N/A) |
4.22 (9.47) |
124.41% | Details | |
| 6/2/2020 | Ocular Therapeutix | OCUL | New Coverage | Market Outperform (N/A) |
7.04 (10.31) |
46.45% | Details |
